Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Cost-Benefit Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost of Illness < Cost-Benefit Analysis < Cost-Benefit Analysis (economics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000266 (2000) A D Siderowf [États-Unis] ; R G Holloway ; M B SternCost-effectiveness analysis in Parkinson's disease: determining the value of interventions.
000A64 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf ; Claire Thalamas ; Monique Galitzky ; Jean-Michel Senard ; Olivier Rascol ; Jean-Louis MontastrucClinical and economic analysis of spa therapy in Parkinson's disease.
000B18 (2003) Antje M. Smala [Allemagne] ; E Annika Spottke ; Olaf Machat ; Uwe Siebert ; Dieter Meyer ; Rudolf Köhne-Volland ; Martin Reuther ; Janeen Duchane ; Wolfgang H. Oertel ; Karin B. Berger ; Richard C. DodelCabergoline versus levodopa monotherapy: a decision analysis.
000E08 (2004) Carl E. Clarke [Royaume-Uni]A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?
000E61 (2004) Keith Wheatley ; Carl E. Clarke ; Natalie Ives ; Richard GrayCabergoline versus levodopa monotherapy.
000E62 (2004) Connie MarrasRe: Cabergoline versus levodopa monotherapy: a decision analysis.
001113 (2005) Aida M. Bertoli-Avella [Pays-Bas] ; José L. Giroud-Benitez ; Ali Akyol ; Egberto Barbosa ; Onno Schaap ; Herma C. Van Der Linde ; Emilia Martignoni ; Leonardo Lopiano ; Paolo Lamberti ; Emiliana Fincati ; Angelo Antonini ; Fabrizio Stocchi ; Pasquale Montagna ; Ferdinando Squitieri ; Paolo Marini ; Giovanni Abbruzzese ; Giovanni Fabbrini ; Roberto Marconi ; Alessio Dalla Libera ; Giorgio Trianni ; Marco Guidi ; Antonio De Gaetano ; Gustavo Boff Maegawa ; Antonino De Leo ; Virgilio Gallai ; Giulia De Rosa ; Nicola Vanacore ; Giuseppe Meco ; Cornelia M. Van Duijn ; Ben A. Oostra ; Peter Heutink ; Vincenzo BonifatiNovel parkin mutations detected in patients with early-onset Parkinson's disease.
001E24 (2007) Francesc Valldeoriola [Espagne] ; Ossama Morsi ; Eduardo Tolosa ; Jordi Rumià ; Maria José Martí ; Pablo Martínez-MartínProspective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease.
002A12 (2010) Keith L. Davis [États-Unis] ; Heather M. Edin ; Jeffery K. AllenPrevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
003A33 (2013) Scott J. Johnson [États-Unis] ; Melissa D. Diener ; Anna Kaltenboeck ; Howard G. Birnbaum ; Andrew D. SiderowfAn economic model of Parkinson's disease: implications for slowing progression in the United States.
004116 (2014) Kevin T. Stroupe [États-Unis] ; Frances M. Weaver ; Lishan Cao ; Dolores Ippolito ; Brandon R. Barton ; Inger E. Burnett-Zeigler ; Robert G. Holloway ; Barbara G. Vickrey ; Tanya Simuni ; Kenneth A. FollettCost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Cost-Benefit Analysis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cost-Benefit Analysis
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024